We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 06. 04. | 장 마감 후 (AMC) | $1.1 | — | — | $1.05B | — | 예정 |
| FY2026 Q1 | 2025. 01. 31. | 시각 미정 | — | $0.52 | — | — | $964.7M | 보고됨 |
| FY2025 Q3 | 2024. 07. 31. | 시각 미정 | — | $1.37 | — | — | $2.88B |
Consensus PT $89.73 · 15 analysts
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Citigroup | — | 의견 유지 | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 03. 07. | Citigroup | — | 의견 유지 | Neutral → Neutral | — | Citigroup: Neutral |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 04. 30. | 시각 미정 | — | $0.85 | — | — | $1.87B | 보고됨 |
Automated summary from public sources · not investment advice
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
표시할 보유 데이터가 없습니다.
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Stored first · Google News · Yahoo Finance (English)
What are Wall Street analysts' target price for Cooper Companies’ stock? - MSN
What are Wall Street analysts' target price for Cooper Companies’ stock? MSN
Citigroup Adjusts PT on Cooper Companies to $69 From $80, Maintains Neutral Rating - Moomoo
Citigroup Adjusts PT on Cooper Companies to $69 From $80, Maintains Neutral Rating Moomoo